Automated ELISA On-Chip for the Detection of Anti-SARS-CoV-2 Antibodies.

ABSTRACT: The COVID-19 pandemic has been the most critical public health issue in modern history due to its highly infectious and deathly potential, and the limited access to massive, low-cost, and reliable testing has significantly worsened the crisis. The recovery and the vaccination of millions of people against COVID-19 have made serological tests highly relevant to identify the presence and levels of SARS-CoV-2 antibodies. Due to its advantages, microfluidic-based technologies represent an attractive alternative to the conventional testing methodologies used for these purposes. In this work, we described the development of an automated ELISA on-chip capable of detecting anti-SARS-CoV-2 antibodies in serum samples from COVID-19 patients and vaccinated individuals. The colorimetric reactions were

SUBMITTER: Gonzalez-Gonzalez E 

PROVIDER: S-EPMC8539637 | biostudies-literature | 2021 Oct

REPOSITORIES: biostudies-literature